The impact of trial inclusion criteria on outcomes in DLBCL patients treated with R-CHOP in the first line: a Danish nationwide study-Reference-Cited by-同舟云学术

The impact of trial inclusion criteria on outcomes in DLBCL patients treated with R-CHOP in the first line: a Danish nationwide study

Published:2024-09-03 Issue: Volume: Page:1-9
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Simonsen Mikkel Runason¹,Haunstrup Laura Mors¹,Severinsen Freja Tang¹,Jensen Rasmus Kuhr¹,Brown Peter de Nully²,Maurer Matthew J.³^ORCID,Khurana Arushi⁴,Jensen Paw¹^ORCID,Jørgensen Judit Mészáros⁵,Stauffer Larsen Thomas⁶,Clausen Michael Roost⁷,Poulsen Christian Bjørn⁸,Dessau-Arp Andriette⁹,El-Galaly Tarec Christoffer¹⁶¹⁰¹¹,Jakobsen Lasse Hjort¹¹²

Affiliation:

1. Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark

2. Department of Hematology, Copenhagen University Hospital, Copenhagen, Denmark

3. Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA

4. Division of Hematology, Mayo Clinic, Rochester, MN, USA

5. Department of Hematology, Aarhus University Hospital, Aarhus, Denmark

6. Department of Hematology, Odense University Hospital, Odense, Denmark

7. Department of Hematology, Vejle Hospital, Vejle, Denmark

8. Department of Hematology, Zealand University Hospital, Roskilde, Denmark

9. Department of Hematology, Sydvestjysk Sygehus, Esbjerg, Denmark

10. Department of Clinical Medicine, Aalborg University, Aalborg, Denmark

11. Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden